DDIT4 Blocking Peptide (C-term)

DDIT4 Blocking Peptide (C-term)

€363.00
In stock
SKU
AC-BP6268b
Catalog Number: AC-BP6268b
Size: 500 µg
Datasheet
Request Information
Background:
REDD1 is a novel transcriptional target of p53 induced following DNA damage. During embryogenesis, REDD1 expression mirrors the tissue-specific pattern of the p53 family member p63, and TP63 null embryos show virtually no expression of REDD1, which is restored in mouse embryo fibroblasts following p63 expression. In differentiating primary keratinocytes, TP63 and REDD1 expression are coordinately downregulated, and ectopic expression of either gene inhibits in vitro differentiation. REDD1 appears to function in the regulation of reactive oxygen species (ROS); TP63 null fibroblasts have decreased ROS levels and reduced sensitivity to oxidative stress, which are both increased following ectopic expression of either TP63 or REDD1. Thus, REDD1 encodes a shared transcriptional target that implicates ROS in the p53-dependent DNA damage response and in p63-mediated regulation of epithelial differentiation.

Other Names:
DNA damage-inducible transcript 4 protein, HIF-1 responsive protein RTP801, Protein regulated in development and DNA damage response 1, REDD-1, DDIT4, REDD1, RTP801

Target/Specificity:
The synthetic peptide sequence is selected from aa 213-227 of HUMAN DDIT4

Gene Name: DDIT4

Gene ID: 54541
Primary Accession: Q9NX09
Other Accession: Q8VHZ9; Q9D3F7; Q08E62
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:DDIT4 Blocking Peptide (C-term)